跳至主要内容
临床试验/NCT02199080
NCT02199080已完成不适用

Etude du Dosage Des d-dimères sériques Pour le Diagnostic d'Exclusion Des Thrombi Intra-atriaux Avant Ablation Endocavitaire de Fibrillation Atriale

Groupe Hospitalier de la Rochelle Ré Aunis38 个研究点 分布在 1 个国家目标入组 2,506 人开始时间: 2014年7月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,506
试验地点
38
主要终点
Number of Patients With Atrial Thrombus Diagnosed by Transoesophageal Ultrasound

研究概览

简要总结

The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age> 18 years.
  • Patients hospitalized for ablation of atrial fibrillation or symptomatic left flutter
  • Patient informed of the study

排除标准

  • Age <18 years.
  • Patients under guardianship
  • Pregnant woman
  • Contraindication to transesophageal echocardiography
  • transesophageal echocardiography made in another center as the center of ablation
  • Refusal of the patient to participate in the study
  • Patient participating in another interventional study in which an intervention related to biomedical research is performed before the transesophageal echocardiography

结局指标

主要结局

Number of Patients With Atrial Thrombus Diagnosed by Transoesophageal Ultrasound

时间窗: up to 48 hours before ablation

次要结局

  • Risk Factors(48 hours before ablation)
  • Atrial Thrombus Exclusion (ATE) Score(48 hours before ablation)
  • CHADS2 Score(48 hours before ablation)

研究者

发起方
Groupe Hospitalier de la Rochelle Ré Aunis
申办方类型
Other
责任方
Sponsor

研究点 (38)

Loading locations...

相似试验